Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Paris

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Expert Opinion on Pharmacotherapy|February 14, 2020
Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitorsGiovanna Garufi, Antonella Palazzo, Ida Paris, et al.
Breast (Edinburgh, Scotland)|October 12, 2017
Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individualsConcetta Santonocito, Margherita Scapaticci, Donatella Guarino, et al.
Journal of Personalized Medicine|July 2, 2021
Oligometastatic Breast Cancer: How to Manage It?Vittoria Barberi, Antonella Pietragalla, Gianluca Franceschini, et al.
Anticancer Research|January 10, 2014
Esophageal stenosis: a differential diagnosis between esophageal cancer and metastasis from other neoplasiaIda Paris, Arsela Prelaj, Concetta Elisa Onesti, et al.
Life (Basel, Switzerland)|January 28, 2026
Neuroinflammation and the Female Brain: Sex-Specific Mechanisms Underlying Mood Disorders and Stress VulnerabilityGiuseppe Marano, Claudia d'Abate, Gianandrea Traversi, et al.
Frontiers in Oncology|February 8, 2024
Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questionsDaniele Generali, Rossana Berardi, Michele Caruso, et al.
Anticancer Research|October 3, 2014
Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should knowChiara D'Antonio, Annalisa Milano, Riccardo Righini, et al.
Frontiers in Oncology|January 8, 2024
Aromatase inhibitors: the journey from the state of the art to clinical open questionsDaniele Generali, Rossana Berardi, Michele Caruso, et al.
American Journal of Obstetrics and Gynecology|May 28, 2017
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter studyMarco Petrillo, Claudia Marchetti, Rossella De Leo, et al.
Cancers|September 9, 2022
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel AgentsGiovanna Garufi, Luisa Carbognin, Francesco Schettini, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Expert Opinion on Pharmacotherapy|February 14, 2020
Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitorsGiovanna Garufi, Antonella Palazzo, Ida Paris, et al.
Breast (Edinburgh, Scotland)|October 12, 2017
Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individualsConcetta Santonocito, Margherita Scapaticci, Donatella Guarino, et al.
Journal of Personalized Medicine|July 2, 2021
Oligometastatic Breast Cancer: How to Manage It?Vittoria Barberi, Antonella Pietragalla, Gianluca Franceschini, et al.
Anticancer Research|January 10, 2014
Esophageal stenosis: a differential diagnosis between esophageal cancer and metastasis from other neoplasiaIda Paris, Arsela Prelaj, Concetta Elisa Onesti, et al.
Life (Basel, Switzerland)|January 28, 2026
Neuroinflammation and the Female Brain: Sex-Specific Mechanisms Underlying Mood Disorders and Stress VulnerabilityGiuseppe Marano, Claudia d'Abate, Gianandrea Traversi, et al.
Frontiers in Oncology|February 8, 2024
Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questionsDaniele Generali, Rossana Berardi, Michele Caruso, et al.
Anticancer Research|October 3, 2014
Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should knowChiara D'Antonio, Annalisa Milano, Riccardo Righini, et al.
Frontiers in Oncology|January 8, 2024
Aromatase inhibitors: the journey from the state of the art to clinical open questionsDaniele Generali, Rossana Berardi, Michele Caruso, et al.
American Journal of Obstetrics and Gynecology|May 28, 2017
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter studyMarco Petrillo, Claudia Marchetti, Rossella De Leo, et al.
Cancers|September 9, 2022
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel AgentsGiovanna Garufi, Luisa Carbognin, Francesco Schettini, et al.
Pageof 10